Jan Kottner
Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative
Kottner, Jan; Jacobi, Lena; Hahnel, Elisabeth; Alam, Murad; Beeckman, Dimitri; Busard, Celine; Chalmers, J.R.; Deckert, Stefanie; Eleftheriadou, Viktoria; Furlan, Karina; Horbach, Sophie E.R.; Kirkham, Jamie J.; Nast, Alexander; Thiboutot, Diane; Thorlacius, Linnea; Weller, Karsten; Williams, Hywel C.; Schmitt, Jochen
Authors
Lena Jacobi
Elisabeth Hahnel
Murad Alam
Dimitri Beeckman
Celine Busard
J.R. Chalmers
Stefanie Deckert
Viktoria Eleftheriadou
Karina Furlan
Sophie E.R. Horbach
Jamie J. Kirkham
Alexander Nast
Diane Thiboutot
Linnea Thorlacius
Karsten Weller
HYWEL WILLIAMS hywel.williams@nottingham.ac.uk
Professor of Dermato-Epidemiology
Jochen Schmitt
Abstract
Results of clinical trials are the most important information source for generating external clinical evidence. The use of different outcomes across trials, which investigate similar interventions for similar patient groups, significantly limits the interpretation, comparability and clinical application of trial results. Core outcome sets (COSs) aim to overcome this limitation. A COS is an agreed standardized collection of outcomes that should be measured and reported in all clinical trials for a specific clinical condition. The Core Outcome Set Initiative within the Cochrane Skin Group (CSG-COUSIN) supports the development of core outcomes in dermatology.
In the second CSG-COUSIN meeting held in 2017, 11 COS development groups working on skin diseases presented their current work. The presentations and discussions identified the following overarching methodological challenges for COS development in dermatology: it is not always easy to define the disease focus of a COS; the optimal method for outcome domain identification and level of detail needed to specify such domains is challenging to many; decision rules within Delphi surveys need to be improved; appropriate ways of patient involvement are not always clear. In addition, there appear to be outcome domains that may be relevant as potential core outcome domains for the majority of skin diseases. The close collaboration between methodologists in the Core Outcome Set Initiative and the international Cochrane Skin Group has major advantages for trialists, systematic reviewers and COS developers.
Citation
Kottner, J., Jacobi, L., Hahnel, E., Alam, M., Beeckman, D., Busard, C., …Schmitt, J. (2018). Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative. British Journal of Dermatology, 178(4), Article e279-e285. https://doi.org/10.1111/bjd.16324
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 16, 2017 |
Online Publication Date | Feb 14, 2018 |
Publication Date | Apr 1, 2018 |
Deposit Date | Oct 20, 2017 |
Publicly Available Date | Feb 15, 2019 |
Journal | British Journal of Dermatology |
Print ISSN | 0007-0963 |
Electronic ISSN | 1365-2133 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 178 |
Issue | 4 |
Article Number | e279-e285 |
DOI | https://doi.org/10.1111/bjd.16324 |
Public URL | https://nottingham-repository.worktribe.com/output/962161 |
Publisher URL | http://onlinelibrary.wiley.com/doi/10.1111/bjd.16324/abstract |
Files
Core outcome sets in dermatology Report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative_.pdf
(<nobr>154 Kb</nobr>)
PDF
You might also like
Different strategies for using topical corticosteroids in people with eczema
(2019)
Journal Article
Navigating the landscape of core outcome set development in dermatology
(2019)
Journal Article